Seattle Genetics, Inc.

NASDAQ: SGEN
$228.74
+$0.00 (+0.0%)
Closing price January 9, 2024

SGEN Articles

Stocks got a big boost on news that Janet Yellen is talking down the Federal Reserve’s desire to hike interest rates no matter what. Investors in 2016 have used rallies a chance to sell, with a...
With just six trading weeks remaining in 2015, and a dip in the market providing better purchase points, the volume of insider buying was about the highest we have seen this fall.
A new report from Cowen points out that many skittish portfolio managers are anxiously awaiting third-quarter numbers to make sure that the biotech thesis is still in place.
Ever since the massive sell-off in August, insider buying has swamped the selling, and this past week was no different.
The windows for insiders to buy and sell stock sure look like they came flying open this week, as insiders at top companies dipped into their wallets and started buying stock big time.
This past week's trading was marked with huge up and down swings and a rise and fall in volatility. Generally, this is the kind of market action that makes strategists nervous.
One thing we have noticed as the market has crept steadily higher this year is that insider buying has never hit a wall.
The insider buying data that hit our screens this week showed not only a marked increase in the trade size, but also in the dollar values.
One would expect that insiders looking to add to their positions would wait for a downturn in the market. That wasn’t the case this past week.
The recent market volatility has allowed many insiders an opportunity to add stock at better price points, especially in the beaten-down energy sector.
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. for Tuesday, September 30, 2014.
In a research note, Leerink analysts mentioned four specific top biotech names that may have the ability to beat current earnings expectations. But 24/7 Wall St. has one caveat.
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Wednesday July 9, 2014. They include Alcoa, BP, Broadcom, Garmin, Gigamon, KKR, Potash and Zillow.
Source: ThinkstockThe biotech meltdown that started in late February was an indiscriminate killer. The top mega-cap sector leaders were shot down in flames along with small cap names that have yet to...
These are the top analyst upgrades, downgrades and initiations seen on Tuesday, May 6, 2014. They include Anadarko Petroleum, BroadSoft, Charles Schwab, KBR, Target and Valero Energy.